Barrington analyst Michael Petusky maintained a Buy rating on Henry Schein (HSIC) today and set a price target of $75. The company’s shares opened today at $60.17.
According to TipRanks.com, Petusky is a 3-star analyst with an average return of 2.5% and a 47.4% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Henry Schein with a $74.25 average price target.
See today’s analyst top recommended stocks >>
Henry Schein’s market cap is currently $9.21B and has a P/E ratio of 19.57. The company has a Price to Book ratio of 3.23.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.
